CDE Catalog

View and download available CureSCi CDEs using filters below. For best results, clear form between searches.

Displaying 5076 - 5100 of 5231
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far right side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification Version Number Version Date CRF Name ©, ® or TM Disease Name Sub Disease Name
C60566 Neurologic disorder preexist new incidence exacerbation follow drug product infusion indicator

Indicator of whether a pre-existing neurological disorder presented exacerbation or a new incidence following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60567 Neurologic disorder preexist new incidence exacerbation follow drug product infusion describe text

Text describing exacerbation or new incidence of a pre-existing neurological disorder following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60568 Rheumatologic autoimmune prior disorder new instance exacerbation follow drug product infusion indicator

Indicator of whether a prior rheumatologic or other autoimmune disorder presented exacerbation or a new instance following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60569 Rheumatologic autoimmune prior disorder new incidence exacerbation follow drug product infusion describe text

Text describing exacerbation or a new incidence of a prior rheumatologic or other autoimmune disorder following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60570 Hematologic disorder new incidence follow drug product infusion indicator

Indicator of whether there was a new incidence of hematologic disorder following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60571 Hematologic disorder new incidence follow drug product infusion describe text

Text describing new incidence of hematologic disorder following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60572 Infection new incidence potential product relate follow drug product infusion indicator

Indicator of whether there was a new incidence of infection that is potentially product-related following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60573 Infection new incidence potential product relate follow drug product infusion describe text

Text describing new incidence of infection that is potentially product-related following drug product infusion.

Supplemental 1.00 2021-04-23 15:02:28.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60574 Transfusion ever indicator

Indicator of whether the subject/participant has ever received a transfusion.

Core 1.00 2021-04-28 14:15:48.0 Transfusion History Sickle Cell Disease Sickle Cell Disease
C60575 Alloantibody red blood cell type

Type(s) of red blood cell (RBC) alloantibodies identified in the subject/participant.

Core 1.00 2021-04-28 14:19:50.0 Transfusion History Sickle Cell Disease Sickle Cell Disease
C60576 Transfusion lifetime total estimate count

Count of the estimated total number of transfusions received by the subject/participant in his or her lifetime.

Core 1.00 2021-04-28 14:21:56.0 Transfusion History Sickle Cell Disease Sickle Cell Disease
C60577 Avascular necrosis before cure indicator

Indicator of whether participant/subject presented with avascular necrosis prior to being cured.

Core 1.00 2021-04-28 14:25:43.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60578 Avascular necrosis anatomic site

Anatomic site(s) of subject/participant's avascular necrosis.

Core 1.00 2021-04-28 14:29:34.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60579 Avascular necrosis Lesion 1 stage number

Number denoting the stage of avascular necrosis at the site of Lesion 1.

Core 1.00 2021-04-28 14:31:15.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60580 Avascular necrosis Lesion 2 stage number

Number denoting the stage of avascular necrosis at the site of Lesion 2.

Core 1.00 2021-04-28 14:31:15.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60581 Avascular necrosis lesion stage number not record reason

Reason why the stage number for the avascular necrosis legion has not been recorded.

Core 1.00 2021-04-28 14:37:09.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60582 Growth hormone receive response deficiency ever indicator

Indicator of whether the subject/participant ever received growth hormone in response to a deficiency thereof.

Core 1.00 2021-04-28 14:41:44.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60583 Hypogonadotropic hypogonadism diagnosis age integer

Integer for the age in years of the subject/participant at the time of his or her diagnosis of hypogonadotropic hypogonadism.

Core 1.00 2021-04-28 14:45:24.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60584 Fertility preservation indicator

Indicator of whether the subject/participant took steps to preserve his or her fertility.

Core 1.00 2021-04-28 14:49:47.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60585 Fertility preservation no reason

Reason given by the subject/participant for why he or she did not take steps to preserve his or her fertility.

Core 1.00 2021-04-28 14:52:44.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60586 Fertility preservation payment source type

Type of payment source for the subject/participant's fertility preservation

Core 1.00 2021-04-28 14:54:40.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60587 Fertility preservation payment insurance copay value

Value in U.S. dollars of the insurance copay paid by the subject/participant for his or her fertility preservation.

Core 1.00 2021-04-28 15:01:15.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60588 Hydroxyurea take time fertility preservation indicator

Indicator of whether the subject/participant was taking hydroxyurea at the time of his or her fertility preservation.

Core 1.00 2021-04-28 15:04:03.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60589 Hydroxyurea stop duration

Duration of time in months for which the subject/participant's hydroxyurea treatment has been stopped.

Core 1.00 2021-04-28 15:06:07.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
C60590 Fertility preservation bank material category

Category of material that has been banked as part of the subject/participant's fertility preservation.

Core 1.00 2021-04-28 15:09:14.0 Endocrine, Infertility and Bone Health Sickle Cell Disease Sickle Cell Disease
Displaying 5076 - 5100 of 5231